TLR9 and cancer: CQ has been shown to inhibit the TLR9/nuclear factor kappa B signaling pathway, thereby reducing cancer invasiveness, and both CQ and HCQ can suppress cancer cell proliferation by interfering with the CXCL12/CXCR4 signaling pathway.